Germany · Investor

Boehringer Ingelheim

Last cheque observed May 2026; 9 cheques on record.

Email

Deploying nowVC firm

Series ASeries BSeries CBiopharmaPharmaceutical

Deploying now
100%of best year1cheques in 12 months, 9 on record
Since the last cheque176days00hrs00min00sec
Median round$12MRounds led1 of 9Mostly inUnited States, 33%
Pitch Boehringer Ingelheim

Boehringer Ingelheim highlights

  1. 01

    1 cheques in the last 12 months

  2. 02

    Mostly Series A and Series B: 75% of its rounds

  3. 03

    Led 1 rounds

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Sectors
BiopharmaPharmaceutical
Based in
Ingelheim am Rhein, Germany
Cold pitches
Not stated

The record

Every round we can evidence, newest first9 appearances

  1. 2026

    1 round

  2. May
    Click TherapeuticsSeries D · US · Revelation Partners$50MLed
  3. 2019

    1 round

  4. Apr
    AgomAB TherapeuticsSeries A · BE · FinSMEs$24MWith 4 others
  5. 2018

    3 rounds

  6. Nov
    WellthSeries A · US · FinSMEs$5.1MWith 5 others
  7. May
    AcousiaSeries B · DE · FinSMEs$12MWith 4 others
  8. Apr
    BrainomixGB · FinSMEs$9.8MWith 2 others
  9. 2017

    4 rounds

  10. Dec
    HookipaSeries C · AT · FinSMEs$60MWith 8 others
  11. May
    Cardior PharmaceuticalsSeries A · DE · FinSMEs$16MWith 4 others
  12. Apr
    Sentien BiotechnologiesSeries A · US · FinSMEs$12MWith 3 others
  13. Jan
    HepaRegeniXSeries A · DE · FinSMEs$9.5MWith 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 2 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

5+funds on filenumbered funds in its name

Companies it bought

Acquisitions by the firm itself

Actimis Pharmaceuticals$515MJun 2008

Recently backed

The latest companies Boehringer Ingelheim put money into.

Click Therapeutics$50M · May 2026AgomAB Therapeutics$24M · Apr 2019Wellth$5.1M · Nov 2018Brainomix$9.8M · Apr 2018Hookipa$60M · Dec 2017Cardior Pharmaceuticals$16M · May 2017

Mentioned on podcasts

Episodes that name Boehringer Ingelheim in their description, not their title.

Quick answers about Boehringer Ingelheim

What does Boehringer Ingelheim invest in?

Boehringer Ingelheim invests most often at Series A and Series B (75% of the rounds on record), in sectors such as Biopharma and Pharmaceutical.

How active is Boehringer Ingelheim?

9 investments on record, 1 of them in the last 12 months, and it led 1. The most recent was in May 2026.

What has Boehringer Ingelheim invested in recently?

Its most recent investments on record: Click Therapeutics (Series D, May 2026), AgomAB Therapeutics (Series A, Apr 2019) and Wellth (Series A, Nov 2018).

How big are Boehringer Ingelheim's cheques?

The median round it joins is $12M.

Does Boehringer Ingelheim lead rounds?

Sometimes: it led 1 of its 9 investments on record (11%).

Where does Boehringer Ingelheim invest?

Most of the companies it backs are in the United States (33%), Germany (33%) and Belgium (11%).

Is Boehringer Ingelheim investing now?

Yes: it is actively investing, with 1 investments in the last 12 months.

What kind of investor is Boehringer Ingelheim?

Boehringer Ingelheim is a VC firm based in Ingelheim am Rhein, Germany.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it